Entry Point Capital, LLC Arvinas, Inc. Transaction History
Entry Point Capital, LLC
- $171 Million
- Q3 2024
A detailed history of Entry Point Capital, LLC transactions in Arvinas, Inc. stock. As of the latest transaction made, Entry Point Capital, LLC holds 21,458 shares of ARVN stock, worth $409,418. This represents 0.31% of its overall portfolio holdings.
Number of Shares
21,458
Previous 4,449
382.31%
Holding current value
$409,418
Previous $118 Million
99.55%
% of portfolio
0.31%
Previous 0.17%
Shares
2 transactions
Others Institutions Holding ARVN
# of Institutions
229Shares Held
68.4MCall Options Held
226KPut Options Held
285K-
Vanguard Group Inc Valley Forge, PA7.01MShares$134 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.73MShares$128 Million7.19% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$119 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.85MShares$73.5 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY2.78MShares$53.1 Million1.09% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $1.02B
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...